70.33 USD
-1.52
2.12%
At close Mar 28, 4:00 PM EDT
After hours
70.20
-0.13
0.18%
1 day
-2.12%
5 days
-4.00%
1 month
-12.03%
3 months
-0.09%
6 months
12.35%
Year to date
0.56%
1 year
11.21%
5 years
59.55%
10 years
36.19%
 

About: Citigroup Inc is a global financial services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.

Employees: 229,000

0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 12 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

229% more first-time investments, than exits

New positions opened: 303 | Existing positions closed: 92

35% more funds holding in top 10

Funds holding in top 10: 46 [Q3] → 62 (+16) [Q4]

17% more repeat investments, than reductions

Existing positions increased: 754 | Existing positions reduced: 646

14% more capital invested

Capital invested by funds: $87.1B [Q3] → $99.7B (+$12.6B) [Q4]

10% more funds holding

Funds holding: 1,758 [Q3] → 1,929 (+171) [Q4]

2.02% more ownership

Funds ownership: 72.87% [Q3] → 74.89% (+2.02%) [Q4]

22% less call options, than puts

Call options by funds: $6.7B | Put options by funds: $8.62B

Research analyst outlook

12 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$79
12%
upside
Avg. target
$91
30%
upside
High target
$110
56%
upside

12 analyst ratings

11 positive
92%
neutral
8%
negative
0%
Goldman Sachs
Richard Ramsden
80% 1-year accuracy
8 / 10 met price target
14%upside
$80
Buy
Maintained
19 Mar 2025
Morgan Stanley
Betsy Graseck
74% 1-year accuracy
35 / 47 met price target
55%upside
$109
Overweight
Maintained
13 Mar 2025
B of A Securities
Ebrahim Poonawala
68% 1-year accuracy
17 / 25 met price target
28%upside
$90
Buy
Maintained
10 Mar 2025
RBC Capital
Gerard Cassidy
48% 1-year accuracy
16 / 33 met price target
21%upside
$85
Outperform
Maintained
16 Jan 2025
Argus Research
Stephen Biggar
83% 1-year accuracy
20 / 24 met price target
24%upside
$87
Buy
Maintained
16 Jan 2025

Financial journalist opinion

Based on 38 articles about C published over the past 30 days

Positive
CNBC
3 days ago
Former Citi CEO Sandy Weill launches new cancer research hub focused on immunotherapy
Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on immunotherapy. The hub is in partnership with four leading research institutions.
Former Citi CEO Sandy Weill launches new cancer research hub focused on immunotherapy
Positive
Zacks Investment Research
4 days ago
Citigroup (C) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Citigroup (C) have what it takes?
Citigroup (C) Could Be a Great Choice
Positive
Zacks Investment Research
5 days ago
Why Citigroup (C) Outpaced the Stock Market Today
In the latest trading session, Citigroup (C) closed at $74.47, marking a +0.58% move from the previous day.
Why Citigroup (C) Outpaced the Stock Market Today
Neutral
Business Wire
5 days ago
Citi Appointed as Depositary Bank for Nightingale Health OYJ's ADR Program
LONDON--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ (“Nightingale Health”) to act as depositary bank for its sponsored Level 1 American Depositary Receipt (“ADR”) program. Nightingale Health's ADRs are traded on the OTCQX platform under the symbol “NHLTY”. Each ADR represents one ordinary share of the company. Nightingale Health's underlying ordinary shares are listed and traded on the Nasdaq Helsinki Stock Exchange under the.
Citi Appointed as Depositary Bank for Nightingale Health OYJ's ADR Program
Positive
Zacks Investment Research
6 days ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
The Motley Fool
1 week ago
Citigroup Stock Has Lost 16% in the Market Sell-Off. Is It a Buy?
The S&P 500 index (^GSPC 0.08%) quickly fell into correction territory not too long ago. Dropping alongside the index were the shares of Citigroup (C 0.17%).
Citigroup Stock Has Lost 16% in the Market Sell-Off. Is It a Buy?
Positive
Zacks Investment Research
1 week ago
Investors Heavily Search Citigroup Inc. (C): Here is What You Need to Know
Citigroup (C) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search Citigroup Inc. (C): Here is What You Need to Know
Neutral
Zacks Investment Research
1 week ago
Fed Keeps Rates Steady, Ups Inflation Target: How are Banks Affected?
The Fed raises the inflation target and cuts growth projections due to Trump's tariffs, dimming the outlook for banks like JPM, BAC, C, CMA and KEY.
Fed Keeps Rates Steady, Ups Inflation Target: How are Banks Affected?
Neutral
Zacks Investment Research
1 week ago
Citigroup Slashes Top Executives Bonus in 2024 for Regulatory Fixes
C reduces top executives' bonuses in 2024 tied to the bank's turnaround results and risk management fixes required by regulators.
Citigroup Slashes Top Executives Bonus in 2024 for Regulatory Fixes
Negative
Reuters
1 week ago
Citigroup reduces bonuses paid in 2024 for regulatory fixes
Citigroup paid top executives smaller bonuses last year tied to results of the bank's turnaround and risk management fixes required by regulators, the bank's proxy filing on Tuesday showed.
Citigroup reduces bonuses paid in 2024 for regulatory fixes
Charts implemented using Lightweight Charts™